{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:26:19Z","timestamp":1777562779214,"version":"3.51.4"},"reference-count":37,"publisher":"Japanese Society for Lymphoreticular Tissue Research","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JCEH","J Clin Exp Hematopathol"],"published-print":{"date-parts":[[2024]]},"DOI":"10.3960\/jslrt.23038","type":"journal-article","created":{"date-parts":[[2024,1,27]],"date-time":"2024-01-27T22:10:51Z","timestamp":1706393451000},"page":"1-9","source":"Crossref","is-referenced-by-count":5,"title":["Analysis of Notch1 protein expression in methotrexate-associated lymphoproliferative disorders"],"prefix":"10.3960","volume":"64","author":[{"given":"Takeshi","family":"Okatani","sequence":"first","affiliation":[{"name":"Department of Hematology, Hiroshima Red Cross Hospital &amp; Atomic-bomb Survivors Hospital, Hiroshima, Japan,"},{"name":"Department of Pathology and Oncology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Midori Filiz","family":"Nishimura","sequence":"additional","affiliation":[{"name":"Department of Molecular Hematopathology, Okayama University Graduate School of Health Sciences, Okayama, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuria","family":"Egusa","sequence":"additional","affiliation":[{"name":"Department of Molecular Hematopathology, Okayama University Graduate School of Health Sciences, Okayama, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sayako","family":"Yoshida","sequence":"additional","affiliation":[{"name":"Department of Molecular Hematopathology, Okayama University Graduate School of Health Sciences, Okayama, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshito","family":"Nishimura","sequence":"additional","affiliation":[{"name":"Department of Medicine, University of Hawai\u2019i, Honolulu, HI, USA,"},{"name":"Department of General Medicine, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asami","family":"Nishikori","sequence":"additional","affiliation":[{"name":"Department of Molecular Hematopathology, Okayama University Graduate School of Health Sciences, Okayama, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Yoshino","sequence":"additional","affiliation":[{"name":"Department of Pathology and Oncology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hidetaka","family":"Yamamoto","sequence":"additional","affiliation":[{"name":"Department of Pathology and Oncology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuharu","family":"Sato","sequence":"additional","affiliation":[{"name":"Department of Molecular Hematopathology, Okayama University Graduate School of Health Sciences, Okayama, Japan,"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2349","reference":[{"key":"1","unstructured":"1 Rath T, Rubbert A. Drug combinations with methotrexate to treat rheumatoid arthritis. Clin Exp Rheumatol. 2010; 28: S52-S57."},{"key":"2","unstructured":"2 Ellman MH, Hurwitz H, Thomas C, Kozloff M. Lymphoma developing in a patient with rheumatoid arthritis taking low dose weekly methotrexate. J Rheumatol. 1991; 18: 1741-1743."},{"key":"3","unstructured":"3 Swerdlow SH, Campo E, Harris NL, <i>et al.<\/i> WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed, Lyon, IARC Press. 2017."},{"key":"4","doi-asserted-by":"crossref","unstructured":"4 Cree IA. The WHO Classification of Haematolymphoid Tumours. Leukemia. 2022; 36: 1701-1702.","DOI":"10.1038\/s41375-022-01625-x"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5 Ichikawa A, Arakawa F, Kiyasu J <i>et al.<\/i> Methotrexate\/iatrogenic lymphoproliferative disorders in rheumatoid arthritis: histology, E pstein\u2013 B arr virus, and clonality are important predictors of disease progression and regression. Eur J Haematol. 2013; 91: 20-28.","DOI":"10.1111\/ejh.12116"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6 Kurita D, Miyoshi H, Ichikawa A <i>et al.<\/i> Methotrexate-associated lymphoproliferative disorders in patients with rheumatoid arthritis: Clinicopathologic features and prognostic factors. Am J Surg Pathol. 2019; 43: 869-884.","DOI":"10.1097\/PAS.0000000000001271"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7 Satou A, Tabata T, Miyoshi H <i>et al.<\/i> Methotrexate-associated lymphoproliferative disorders of T-cell phenotype: clinicopathological analysis of 28 cases. Mod Pathol. 2019; 32: 1135-1146.","DOI":"10.1038\/s41379-019-0264-2"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8 Satou A, Nakamura S. EBV\u2010positive B\u2010cell lymphomas and lymphoproliferative disorders: Review from the perspective of immune escape and immunodeficiency. Cancer Med. 2021; 10: 6777-6785.","DOI":"10.1002\/cam4.4198"},{"key":"9","unstructured":"9 Gaulard P, Swerdlow S, Harris N, Jaffe E, Sundstr\u00f6m C. Other iatrogenic immunodeficiency-associated lymphoproliferative disorders. In: Swerdlow SH, Campo E, Harris NL, <i>et al.<\/i> (eds): World Health Organization Classification of Tumours of Haematopoietic and Lymphoid Tissues. Lyon, IARC Press. 2008; pp. 350-351."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10 Saito S, Takeuchi T. Immune response in LPD during methotrexate administration (MTX-LPD) in rheumatoid arthritis patients. J Clin Exp Hematop. 2019; 59: 145-155.","DOI":"10.3960\/jslrt.19028"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11 Baecklund E, Iliadou A, Askling J <i>et al.<\/i> Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis. Arthritis Rheum. 2006; 54: 692-701.","DOI":"10.1002\/art.21675"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12 Ruhland MK, Loza AJ, Capietto AH <i>et al.<\/i> Stromal senescence establishes an immunosuppressive microenvironment that drives tumorigenesis. Nat Commun. 2016; 7: 11762.","DOI":"10.1038\/ncomms11762"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13 Emilie D, Zou W, Fior R <i>et al.<\/i> Production and roles of IL-6, IL-10, and IL-13 in B-lymphocyte malignancies and in B-lymphocyte hyperactivity of HIV infection and autoimmunity. Methods. 1997; 11: 133-142.","DOI":"10.1006\/meth.1996.0397"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14 Fitzsimmons L, Kelly GL. EBV and apoptosis: The viral master regulator of cell fate? Viruses. 2017; 9: 339.","DOI":"10.3390\/v9110339"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15 Thorley-Lawson DA, Gross A. Persistence of the Epstein-Barr virus and the origins of associated lymphomas. N Engl J Med. 2004; 350: 1328-1337.","DOI":"10.1056\/NEJMra032015"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16 Shimoyama Y, Yamamoto K, Asano N <i>et al.<\/i> Age\u2010related Epstein-Barr virus\u2010associated B\u2010cell lymphoproliferative disorders: special references to lymphomas surrounding this newly recognized clinicopathologic disease. Cancer Sci. 2008; 99: 1085-1091.","DOI":"10.1111\/j.1349-7006.2008.00813.x"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17 Gion Y, Iwaki N, Takata K <i>et al.<\/i> Clinicopathological analysis of methotrexate\u2010associated lymphoproliferative disorders: Comparison of diffuse large B\u2010cell lymphoma and classical Hodgkin lymphoma types. Cancer Sci. 2017; 108: 1271-1280.","DOI":"10.1111\/cas.13249"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18 Ueda Y, Tanaka T, Asakura S, Yano T. A case of classic Hodgkin lymphoma arising after remission of methotrexate-associated follicular lymphoma. J Clin Exp Hematop. 2023; 63: 177-180.","DOI":"10.3960\/jslrt.23016"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19 Gion Y, Doi M, Nishimura Y <i>et al.<\/i> PD\u2010L1 expression is associated with the spontaneous regression of patients with methotrexate\u2010associated lymphoproliferative disorders. Cancer Med. 2022; 11: 417-432.","DOI":"10.1002\/cam4.4462"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20 Roemer MGM, Advani RH, Ligon AH <i>et al.<\/i> PD-L1 and PD-L2 genetic alterations define classical Hodgkin lymphoma and predict outcome. J Clin Oncol. 2016; 34: 2690-2697.","DOI":"10.1200\/JCO.2016.66.4482"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21 Takahara T, Sakakibara A, Tsuyuki Y <i>et al.<\/i> Diagnostic approach for classic Hodgkin lymphoma in small samples with an emphasis on PD-L1 expression and EBV harboring in tumor cells: a brief review from morphology to biology. J Clin Exp Hematop. 2023; 63: 58-64.","DOI":"10.3960\/jslrt.23003"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22 Kumar R, Juillerat-Jeanneret L, Golshayan D. Notch antagonists: Potential modulators of cancer and inflammatory diseases. J Med Chem. 2016; 59: 7719-7737.","DOI":"10.1021\/acs.jmedchem.5b01516"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23 Landau DA, Tausch E, Taylor-Weiner AN <i>et al.<\/i> Mutations driving CLL and their evolution in progression and relapse. Nature. 2015; 526: 525-530.","DOI":"10.1038\/nature15395"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24 Kridel R, Meissner B, Rogic S <i>et al.<\/i> Whole transcriptome sequencing reveals recurrent NOTCH1 mutations in mantle cell lymphoma. Blood. 2012; 119: 1963-1971.","DOI":"10.1182\/blood-2011-11-391474"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25 Kiel MJ, Velusamy T, Betz BL <i>et al.<\/i> Whole-genome sequencing identifies recurrent somatic NOTCH2 mutations in splenic marginal zone lymphoma. J Exp Med. 2012; 209: 1553-1565.","DOI":"10.1084\/jem.20120910"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26 Lee SY, Kumano K, Nakazaki K <i>et al.<\/i> Gain\u2010of\u2010function mutations and copy number increases of Notch2 in diffuse large B\u2010cell lymphoma. Cancer Sci. 2009; 100: 920-926.","DOI":"10.1111\/j.1349-7006.2009.01130.x"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27 Li Z, Yu F, Ye W <i>et al.<\/i> Clinical features and prognostic significance of NOTCH1 mutations in diffuse large B-cell lymphoma. Front Oncol. 2021; 11: 746577.","DOI":"10.3389\/fonc.2021.746577"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28 Lohr JG, Stojanov P, Lawrence MS <i>et al.<\/i> Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing. Proc Natl Acad Sci USA. 2012; 109: 3879-3884.","DOI":"10.1073\/pnas.1121343109"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29 Karube K, Mart\u00ednez D, Royo C <i>et al.<\/i> Recurrent mutations of NOTCH genes in follicular lymphoma identify a distinctive subset of tumours. J Pathol. 2014; 234: 423-430.","DOI":"10.1002\/path.4428"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30 Butzmann A, Sridhar K, Jangam D <i>et al.<\/i> Mutations in JAK\/STAT and NOTCH1 genes are enriched in post-transplant lymphoproliferative disorders. Front Oncol. 2022; 11: 790481.","DOI":"10.3389\/fonc.2021.790481"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31 Nguyen TB, Sakata-Yanagimoto M, Asabe Y <i>et al.<\/i> Identification of cell-type-specific mutations in nodal T-cell lymphomas. Blood Cancer J. 2017; 7: e516.","DOI":"10.1038\/bcj.2016.122"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32 Jegalian AG, Bodo J, Hsi ED. NOTCH1 intracellular domain immunohistochemistry as a diagnostic tool to distinguish T-lymphoblastic lymphoma from thymoma. Am J Surg Pathol. 2015; 39: 565-572.","DOI":"10.1097\/PAS.0000000000000358"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33 Shiraiwa S, Kikuti YY, Carreras J <i>et al.<\/i> Clinicopathological evaluation of methotrexate-associated lymphoproliferative disorders with special focus on Epstein-Barr virus-positive mucocutaneous lesions. J Clin Exp Hematop. 2020; 60: 159-168.","DOI":"10.3960\/jslrt.20041"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34 Ebeo CT, Girish MR, Byrd RP, Roy TM, Mehta JB. Methotrexate-induced pulmonary lymphoma. Chest. 2003; 123: 2150-2153.","DOI":"10.1378\/chest.123.6.2150"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35 Kameda H, Okuyama A, Tamaru J <i>et al.<\/i> Lymphomatoid granulomatosis and diffuse alveolar damage associated with methotrexate therapy in a patient with rheumatoid arthritis. Clin Rheumatol. 2007; 26: 1585-1589.","DOI":"10.1007\/s10067-006-0480-2"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36 Sakata-Yanagimoto M. A translational research in angioimmunoblastic T-cell lymphoma. Journal of The Society of Japanese Women Scientists. 2021; 21: 1-12.","DOI":"10.5939\/sjws.21001"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37 Mangolini M, Maiques-Diaz A, Charalampopoulou S <i>et al.<\/i> Viral transduction of primary human lymphoma B cells reveals mechanisms of NOTCH-mediated immune escape. Nat Commun. 2022; 13: 6220.","DOI":"10.1038\/s41467-022-33739-2"}],"container-title":["Journal of Clinical and Experimental Hematopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/64\/1\/64_23038\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,30]],"date-time":"2024-03-30T05:44:55Z","timestamp":1711777495000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jslrt\/64\/1\/64_23038\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.3960\/jslrt.23038","relation":{},"ISSN":["1346-4280","1880-9952"],"issn-type":[{"value":"1346-4280","type":"print"},{"value":"1880-9952","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024]]},"article-number":"23038"}}